End-to-end RNA optimization: Platform combines proprietary AI sequence optimization, novel genetic parts, and lab validation in application-relevant cell models to improve expression and half-life, ...
BOSTON, March 19, 2026 (GLOBE NEWSWIRE)-- Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, today announced the launch of its RNA Edge System, an integrated ...